Article
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
Molecular psychiatry - 1 Nov 1998
Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M
Abstract excerpt
Depression with psychotic features has been shown to respond to selective serotonin reuptake inhibitors (SSRIs). The serotonin transporter (5-HTT) is a prime target for SSRIs. A functional polymorphism within the promoter region of the 5-HTT gene, leading to different transcriptional efficiency,...
Topics
- Antidepressive Agents, Second-Generation
- Carrier Proteins
- Depressive Disorder
- Drug Therapy, Combination
- Female
- Fluvoxamine
- Genotype
- Humans
- Male
- Membrane Glycoproteins
- Membrane Transport Proteins
- Middle Aged
- Nerve Tissue Proteins
- Pindolol
- Polymorphism, Genetic
- Predictive Value of Tests
- Promoter Regions, Genetic
- Serotonin Antagonists
